Find Clascoterone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Clascoterone, 19608-29-8, Cb-03-01, 17 alpha-propionate, 17alpha-propionate, Winlevi
Molecular Formula
C24H34O5
Molecular Weight
402.5  g/mol
InChI Key
GPNHMOZDMYNCPO-PDUMRIMRSA-N
FDA UNII
XN7MM8XG2M

Clascoterone
Clascoterone (cortexolone 17-propionate, CB-03-01) is a novel antagonist of androgen receptors. It binds to androgen receptors with high affinity. By competing with androgens for binding to androgen receptors, clascoterone works by blocking the androgen receptor signalling cascades that promote acne pathogenesis, such as sebaceous gland proliferation, excess sebum production, and inflammatory pathways. In August 2020, FDA approved clascoterone for the first-in-class topical treatment of acne (acne vulgaris) in male and female patients 12 years and older. Clascoterone is also being investigated as a novel treatment for androgenetic alopecia.
Clascoterone is an Androgen Receptor Inhibitor. The mechanism of action of clascoterone is as an Androgen Receptor Antagonist.
1 2D Structure

Clascoterone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate
2.1.2 InChI
InChI=1S/C24H34O5/c1-4-21(28)29-24(20(27)14-25)12-9-19-17-6-5-15-13-16(26)7-10-22(15,2)18(17)8-11-23(19,24)3/h13,17-19,25H,4-12,14H2,1-3H3/t17-,18+,19+,22+,23+,24+/m1/s1
2.1.3 InChI Key
GPNHMOZDMYNCPO-PDUMRIMRSA-N
2.1.4 Canonical SMILES
CCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)CO
2.1.5 Isomeric SMILES
CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO
2.2 Other Identifiers
2.2.1 UNII
XN7MM8XG2M
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cb-03-01

2. Clascoterone

3. Winlevi

2.3.2 Depositor-Supplied Synonyms

1. Clascoterone

2. 19608-29-8

3. Cb-03-01

4. 17 Alpha-propionate

5. 17alpha-propionate

6. Winlevi

7. Cortexolone 17 Alpha-propionate

8. Clascoterone [usan]

9. Xn7mm8xg2m

10. Pregn-4-ene-3,20-dione, 21-hydroxy-17-(1-oxopropoxy)-

11. Cortexolone 17.alpha.-propionate

12. Cortodoxone 17.alpha.-propionate

13. Clascoterone (usan)

14. Pregn-4-ene-3,20-dione, 17,21-dihydroxy-, 17-propionate

15. (8r,9s,10r,13s,14s,17r)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl Propionate

16. [(8r,9s,10r,13s,14s,17r)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] Propanoate

17. Breezula

18. Unii-xn7mm8xg2m

19. Cortodoxone 17alpha-propionate

20. 17

21. A-propionate

22. Clascoterone [mi]

23. Clascoterone [inn]

24. Cortexolone 17a-propionate

25. Clascoterone [who-dd]

26. Schembl1231152

27. Chembl3590187

28. Gtpl11215

29. Dtxsid10471883

30. Clascoterone [orange Book]

31. Bcp02565

32. Ex-a1953

33. Zinc6716459

34. 11-deoxycortisol 17alpha-propionate

35. S6896

36. Akos030526694

37. At22231

38. Bcp9000062

39. Cb-0301

40. Cs-1151

41. Db12499

42. 17alpha-(propionyloxy)deoxycorticosterone

43. Ac-31957

44. Hy-13331

45. Clascoterone; 19608-29-8; Cb-03-1

46. D11451

47. A854304

48. Q27293917

49. 21-hydroxy-3,20-dioxopregn-4-en-17-yl Propanoate

50. Cortexolone 17alpha-propionate;(8r,9s,10r,13s,14s,17r)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl Propionate;cortexolone 17 Alpha-propionate

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 402.5 g/mol
Molecular Formula C24H34O5
XLogP33.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass402.24062418 g/mol
Monoisotopic Mass402.24062418 g/mol
Topological Polar Surface Area80.7 Ų
Heavy Atom Count29
Formal Charge0
Complexity769
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Clascoterone is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Clascoterone exerts anti-androgenic effects by working as an antagonist at androgen receptors (ARs) expressed throughout the skin, including sebaceous glands, sebocytes, and dermal papilla cells. Clascoterone blocks the effects of testosterone and dihydrotestosterone (DHT), which are androgens that bind to the ARs and contribute to the development of androgen-dependent conditions such as acne and alopecia. _In vitro_, the antiandrogenic effects of clascoterone in human primary sebocytes occurred in a dose-dependent manner. Clascoterone mediates selective topical activity by mainly targeting androgen receptors at the site of application. It has limited systemic effects. In clinical trials, HPA axis suppression was observed as a 30-minute post-stimulation serum cortisol level of 18 mcg/dL in 5% of adult subjects and 9% of adolescent subjects with acne vulgaris following two weeks of topical treatment of clascoterone. HPA axis function returned to normal following the discontinuation of drug treatment.


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
CLASCOTERONE
5.2.2 FDA UNII
XN7MM8XG2M
5.2.3 Pharmacological Classes
Androgen Receptor Inhibitor [EPC]; Androgen Receptor Antagonists [MoA]
5.3 ATC Code

D - Dermatologicals

D10 - Anti-acne preparations

D10A - Anti-acne preparations for topical use

D10AX - Other anti-acne preparations for topical use

D10AX06 - Clascoterone


5.4 Absorption, Distribution and Excretion

Absorption

Upon topical application, clascoteronet permeates the skin to the dermal levels with minimal systemic absorption. In clinical trials, adult subjects with moderate to severe facial acne vulgaris received twice-daily topical application of six grams of clascoterone. The steady-state concentrations of the drug were reached within five days. Following two weeks, the mean SD Cmax was 4.5 2.9 ng/mL and the mean SD area under the plasma concentration-time over the dosing interval (AUC) was 37.1 22.3 h*ng/mL. The mean SD average plasma concentration (Cavg) was 3.1 1.9 ng/mL.


Route of Elimination

Excretion of clascoterone has not been fully characterized in humans. Upon topical application, clascoterone is quickly hydrolyzed in the epidermis.


Volume of Distribution

There is no information available on the volume of distribution.


Clearance

There is limited information on clearance of clascoterone.


5.5 Metabolism/Metabolites

According to _in vitro_ and clinical studies, the main possible primary metabolite of clascoterone is cortexolone, which is an inactive metabolite. The plasma concentrations of cortexolone were generally below or near the lower limit of quantitation (0.5 ng/mL). Although clascoterone penetrates the skin, the systemic activity of the drug is limited due to rapid hydrolysis of clascoterone into the inactive metabolite by skin and plasma esterases, namely carboxylesterase.


5.6 Biological Half-Life

There is limited information on the half life of clascoterone.


5.7 Mechanism of Action

Acne is a multifactorial skin condition characterized by excess sebum production, epithelial hyperkeratinization, proliferation of the skin commensal bacteria, and inflammation. Circulating and locally synthesized natural ligands, testosterone and dihydrotestosterone (DHT), serve as causative factors in both males and females. Upon binding of DHT, the DHT-androgen receptor complex dimerizes and translocates to the nucleus where it promotes the transcription of genes involved in acne pathogenesis, including proliferation and differentiation of sebocytes, excess sebum production, and inflammatory cytokine production. Clascoterone is a potent antagonist at ARs and competes for androgens in binding to the receptor, thereby inhibiting downstream signalling of ARs that promote acne. Androgenetic alopecia is also an androgen-dependent and highly genetic condition. Dihydrotestosterone (DHT) binds to ARs expressed on dermal papilla cells (DPC) in the scalp to induce AR-mediated transcription of genes that contribute to androgenic alopecia. By blocking the interaction between DHT and aARs, clascoterone inhibits AR-regulated transcription and DHT-induced IL-6 synthesis.


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687890600,"product":"CLASCOTERONE API (2 LOT, EACH OF 0,5KG)","address":"SPARC TANDALJA","city":"VADODARA","supplier":"M\/S CASSIOPEA S.P.A","supplierCountry":"ITALY","foreign_port":"NA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"5500","totalValueFC":"8047.3","currency":"EUR","unitRateINR":"661455.3","date":"28-Jun-2023","totalValueINR":"661455.312","totalValueInUsd":"8047.3","indian_port":"BOMBAY AIR","hs_no":"29372900","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SPARC TANDALJA"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1690309800,"product":"CLASCOTERONE ( FOR TESTING PURPOSE ONLY)","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"NA","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"0.02","unit":"KGS","unitRateFc":"50000","totalValueFC":"1009.3","currency":"USD","unitRateINR":"4147500.3","date":"26-Jul-2023","totalValueINR":"82950.14","totalValueInUsd":"1009.3","indian_port":"BOMBAY AIR","hs_no":"29372900","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693765800,"product":"CLASCOTERONE (API) (BATCH NO.2CSCRN0OD4069) (CLASCOTERONE) (FOR R&D PURPOSE ONLY)","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV YAFO","customer":"GLENMARK PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.15","actualQuantity":"0.15","unit":"KGS","unitRateFc":"16185.2","totalValueFC":"2453.9","currency":"USD","unitRateINR":"1357938.3","date":"04-Sep-2023","totalValueINR":"203690.74","totalValueInUsd":"2453.9","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"7667044","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV YAFO","supplierAddress":"NEOT HOVAV,PO. BOX 3593, BEER SHEVA, 8413502 ., , IsraelSDNF Israel","customerAddress":"B\/2 MAHALAXMI CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693852200,"product":"CLASCOTERONE (API) (BATCH NO.CSCRN0Y001) (CLASCOTERONE)","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV YAFO","customer":"GLENMARK PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.82","actualQuantity":"1.822","unit":"KGS","unitRateFc":"16185.2","totalValueFC":"29806.2","currency":"USD","unitRateINR":"1357938.1","date":"05-Sep-2023","totalValueINR":"2474163.18","totalValueInUsd":"29806.2","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"7687747","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV YAFO","supplierAddress":"NEOT HOVAV,PO. BOX 3593, BEER SHEVA, 8413502 ., , IsraelSDNF Israel","customerAddress":"B\/2 MAHALAXMI CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704220200,"product":"CLASCOTERONE","address":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV-YAFO","customer":"APL HEALTHCARE","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"19500","totalValueFC":"58984.5","currency":"USD","unitRateINR":"1634100","date":"03-Jan-2024","totalValueINR":"4902300","totalValueInUsd":"58984.5","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29349990","bill_no":"1000032","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV-YAFO","supplierAddress":"N\/A","customerAddress":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704997800,"product":"FOC CLASCOTERONE CAS NO:19608-29-8","address":"NO. 5\/55 KAMDHENU COMPLEX HARI OM,","city":"MUMBAI,MAHARASHTRA","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV YAFO","customer":"MONOLOM INDIA PHARMA ","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"10","totalValueFC":"50.7","currency":"USD","unitRateINR":"842.5","date":"12-Jan-2024","totalValueINR":"4212.5","totalValueInUsd":"50.7","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"9644426","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV YAFO","supplierAddress":"SHLOMO SHMELTZER94 OFER (HI-TECH) PARK PETAH TIKVA ISRAEL Israel, , Israel Israel","customerAddress":"NO. 5\/55 KAMDHENU COMPLEX HARI OM,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706121000,"product":"CLASCOTERONE","address":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV-YAFO","customer":"APL HEALTHCARE","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"18000","totalValueFC":"36428.1","currency":"USD","unitRateINR":"1513800","date":"25-Jan-2024","totalValueINR":"3027600","totalValueInUsd":"36428.1","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29349990","bill_no":"1000269","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV-YAFO","supplierAddress":"N\/A","customerAddress":"3RD FLOOR, PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707762600,"product":"CLASCOTERONE (TEST LIC. NO. TL\/NZ\/21\/000629 DT. 22\/09\/2021)(TEST AND ANALAYSIS)(FOC)","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA PHARMACEUTICAL INDUSTRIES","supplierCountry":"ITALY","foreign_port":"MILAN","customer":"TEVA API","customerCountry":"INDIA","quantity":"0.04","actualQuantity":"37","unit":"GMS","unitRateFc":"10","totalValueFC":"407.8","currency":"EUR","unitRateINR":"914.5","date":"13-Feb-2024","totalValueINR":"33836.5","totalValueInUsd":"407.8","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"2122371","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN","supplierAddress":"SEDE LEGALE:PIAZZALE L.CADOMA 4 20123 MILANOITALY, ITALY","customerAddress":"M-34, SAKET,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708885800,"product":"CLASCOTERONE FORM II DRY","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV YAFO","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"0.14","actualQuantity":"0.139","unit":"KGS","unitRateFc":"22500","totalValueFC":"3162.4","currency":"USD","unitRateINR":"1887750","date":"26-Feb-2024","totalValueINR":"262397.25","totalValueInUsd":"3162.4","indian_port":"Hyderabad Air","hs_no":"29372900","bill_no":"2299669","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV YAFO","supplierAddress":"94 SHLOMO SHMELTZER ROAD, PETACH-TIKVA. P.O.BOX 3158, 4970602 ISRAELSDNF Israel","customerAddress":"PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724005800,"product":"CLASCOTERONE API(UNDER CT-17 SR NO.1)(CONDITION NO.20 FOR CLINICAL TRAIL)(BATCH NO.CSCRN0Z604-4.273KGS\/CSCRN0Z603-2.681K","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV YAFO","customer":"GLENMARK PHARMACEUTICALS","customerCountry":"INDIA","quantity":"10.66","actualQuantity":"10.659","unit":"KGS","unitRateFc":"18500","totalValueFC":"199475.3","currency":"USD","unitRateINR":"1569725","date":"19-Aug-2024","totalValueINR":"16731698.78","totalValueInUsd":"199475.3","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"5128684","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV YAFO","supplierAddress":"94 SHLOMO SHMELTZER ROAD, PETACH-TIKVA P.O.BOX 3158, 4970602 ISRAEL Petah Tikva, , Israel Israel","customerAddress":"B\/2 MAHALAXMI CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726684200,"product":"CLASCOTERONE (BATCH NO.CSCRN0Z603)(UNDER CT-17 SR NO.1) (CONDITION NO.20 FOR CLINICAL TRIAL) (CLASCOTERONE (API))","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"WAVELENGTH PHARMACEUTICALS","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV YAFO","customer":"GLENMARK PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"18500","totalValueFC":"9371.3","currency":"USD","unitRateINR":"1570650","date":"19-Sep-2024","totalValueINR":"785325","totalValueInUsd":"9371.3","indian_port":"Bombay Air","hs_no":"29372900","bill_no":"5678990","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV YAFO","supplierAddress":"NEOT HOVAV,PO. BOX 3593, BEER SHEVA , 8413502 ., , Israel SDNF Israel","customerAddress":"B\/2 MAHALAXMI CHAMBERS"}]
28-Jun-2023
19-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more